Randomised controlled trial (RCT) designs are widely regarded by the m
edical establishment as the trial design of choice, believed to offer
greater internal validity than non-random trials. However, where patie
nts have preferences among treatments to be compared, randomisation ca
n create differences between groups in a trial. The limitations of con
ventional RCTs are considered in the context of treatments for chronic
conditions where patients often have strong treatment preferences. Pr
ecautions required in selection and recruitment of patients into RCTs
are recommended together with strategies for evaluating any effects of
preferences. Alternative trial designs which take account of patients
' and/or doctors' preferences when recruiting patients and allocating
treatments are reviewed, including Brewin and Bradley's increasingly w
idely used partially-randomised preference trial (PRPT) design. Recomm
endations are made for future use of trial designs which take account
of preferences and provide interpretable results of value to clinician
s and patients in routine clinical practice.